Breaking News
Top News
-
Ask an Advisor: Can I Invest in a Real Estate Project Within My Roth IRA? Will the Future Growth and Income Be Tax-Free?
-
Gold price today, Monday, April 6: Gold strengthens after improved jobs report and mixed war news
-
Neurocrine to buy Soleno Therapeutics for $2.9 billion
-
Rachel Cruze Caps Stay-At-Home Mom’s Untested Etsy Dream At $500 While Couple Tackles $75,000 Debt
-
I’m a sandwich Gen Xer who has taken my parents into my home, but I’m paying all the bills. What can I do?
-
Chipotle vs Texas Roadhouse: Which Restaurant Stock Is the Better Long-Term Buy?
-
Italy fines Revolut over consumer code breaches
-
3 Powerful Nuclear Energy Stocks to Buy in April
-
This Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.
-
Prediction: Palantir Will Do the Unthinkable and Fall Below $100 Before 2026 Comes to a Close
-
Reserve Bank of India clears Emirates NBD’s stake purchase in RBL Bank
-
6 regrets early retirees commonly report — and how to avoid making the same mistakes
-
Tesla Bounces Back After Disappointing Deliveries. This Matters More for the Stock.
-
Bitcoin and ethereum price today, Monday, April 6, 2026: Prices rise amid reports of a proposed Iran war ceasefire
-
Indonesia moves to unify state banks’ asset management units – report
-
Is the world running out of oil? Here are three ways Goldman Sachs is answering that critical question.
-
Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.
-
$10,000 a Month for Long-Term Care Is Becoming the Norm—What That Means for Families
-
Using Your 401(k) for a Down Payment Could Cost Your Retirement Savings More Than You Think
-
‘Good to be Home’: Savannah Guthrie Returns to ‘Today’
2026-02-05



































